Drugs / Ferinject
Trials 15
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT02599012 | Sep 2015 → Oct 2017 | anemia, cancer | Samsung Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT02628860 | Jan 2014 → Apr 2020 | anemia, malignant pancreatic neoplasm | National Cancer Center, Korea | Completed | No outcome recorded |
| Phase 2 | NCT00882414 | Dec 2006 → Jan 2010 | iron deficiency anemia, thrombocytosis disease | Vifor Pharma | Terminated | No outcome recorded Stop: Enrollment |
| Phase 35 trials · 1 met primary | ||||||
| Phase 3 | NCT05226169 | Apr 2022 → Nov 2026 expected | gastric carcinoma | Asan Medical Center | Recruiting | No outcome recorded |
| Phase 3 | NCT04187716 | Feb → Dec 2020 | anemia | Samsung Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT01725789 | Nov 2012 → Apr 2016 | anemia | National Cancer Center, Korea | Completed | No outcome recorded |
| Phase 3 | NCT01394562 | Jul 2011 → May 2016 | disorder of iron metabolism and transport, heart failure | Vifor Pharma | Completed | Met primary |
| Phase 3 | NCT00821717 | Dec 2008 → Oct 2009 | disorder of iron metabolism and transport, iron deficiency anemia, symptomatic heart failure | Vifor Pharma | Terminated | No outcome recorded Stop: Enrollment |
| Phase 46 trials · 2 met primary | ||||||
| Phase 4 | NCT05708170 | Jan 2023 → Aug 2026 overdue | iron deficiency anemia | Liverpool Hope University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05759078 | Sep 2022 → Dec 2026 expected | acute myocardial infarction | Wroclaw Medical University | Recruiting | No outcome recorded |
| Phase 4 | NCT05114278 | Jul 2022 | celiac disease | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 4 | NCT04616092 | Nov 2020 → Nov 2022 | brain aneurysm, iron deficiency anemia | Seoul National University Hospital | Unknown | Met primary |
| Phase 4 | NCT05429749 | Jul 2020 → Dec 2023 | — | Seoul National University Bundang Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01453608 | Oct 2011 → Feb 2014 | disorder of iron metabolism and transport, heart failure | Vifor Pharma | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT03625661 | Feb 2014 → Jun 2017 | iron deficiency anemia | Institut Cancerologie de l'Ouest | Completed | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 2 | NCT01447628 Comparator | Mar 2011 → Dec 2017 | disorder of iron metabolism and transport, pulmonary arterial hypertension | Imperial College London | Completed | No outcome recorded |
| Phase 4 | NCT06061393 Comparator | Oct 2023 → Sep 2025 | iron deficiency anemia | Western Galilee Hospital-Nahariya | Unknown | No outcome recorded |
| Phase 4 | NCT05793996 Comparator | Apr 2023 → Dec 2026 expected | disorder of iron metabolism and transport, heart failure | Tomsk National Research Medical Center of the Russian Academy of Sciences | Recruiting | No outcome recorded |
| Phase 4 | NCT03388385 Comparator | Sep 2017 → Dec 2020 | anemia, disorder of defective peroxisome oxidative status, iron poisoning | Carol Davila University of Medicine and Pharmacy | Unknown | No outcome recorded |
| Phase 4 | NCT02939794 Comparator | Nov 2016 → Aug 2018 | anemia | Rambam Health Care Campus | Unknown | No outcome recorded |
| Phase 4 | NCT01975272 Comparator | Mar 2015 → May 2018 | — | Maastricht University Medical Center | Terminated | No outcome recorded |
Press releases naming this drug 8 releases
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 22 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ferinject | “From November 2018 to April 2019, FERINJECT 500mg was administered to 12 patients who underwent clipping surgery for UIAs.” NCT04616092 ↗ |
| Known as | Ferric carboxymaltose | “This is a clinical trial to evaluate the effect of intravenous iron supplement with Ferinject (Ferric Carboxymaltose) in preventing postoperative delirium after hip fracture surgery.” NCT05429749 ↗8“Ferinject ® (Ferric carboxymaltose)” NCT00821717 ↗ “FERINJECT® (Ferric carboxymaltose)” NCT00882414 ↗ “Ferinject (ferric carboxymaltose)” NCT01453608 ↗ “Ferinject (ferric carboxymaltose)” NCT01394562 ↗ “Ferinject (Ferric Carboxymaltose)” NCT02628860 ↗ “ferric carboxymaltose (Ferinject)” PMID 33735594 ↗ Jun 2021 “Ferric carboxymaltose” NCT05793996 ↗ “ferric carboxymaltose” NCT02939794 ↗ |
| Route | Intravenous | “Intravenous Ferric Carboxymaltose” NCT00821717 ↗ |